Medicine & Life Sciences
Autoimmune Diseases
100%
Autoimmunity
67%
SARS Virus
64%
Coronavirus
61%
Autoantibodies
43%
Systematic Reviews
32%
Rheumatoid Arthritis
31%
T-Lymphocytes
31%
Colombia
31%
Meta-Analysis
24%
Thyroid Diseases
24%
Latin America
23%
Systemic Lupus Erythematosus
20%
Pandemics
19%
Antibodies
16%
ETP-46321
16%
Molecular Mimicry
15%
Vaccination
14%
Vaccines
14%
Type 1 Diabetes Mellitus
13%
Cytokines
13%
Phosphatidylinositol 3-Kinases
12%
Population
12%
Systemic Scleroderma
12%
Severe Acute Respiratory Syndrome
12%
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome
11%
Ecology
11%
Biliary Liver Cirrhosis
11%
Infections
11%
4-1BB Ligand
11%
Immunoglobulin G
11%
SS-A antibodies
11%
Immune System
10%
Zika Virus Infection
10%
Extracellular Traps
10%
Metabolomics
10%
Biomarkers
9%
Microscopic Angioscopy
9%
Zika Virus
9%
Polymyalgia Rheumatica
9%
Epitopes
9%
Phosphoinositide-3 Kinase Inhibitors
9%
Therapeutics
9%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
9%
Viral Envelope Proteins
9%
Ebola Hemorrhagic Fever
9%
glucose-regulated proteins
9%
Cluster Analysis
8%
Primary Immunodeficiency Diseases
8%
Rheumatic Diseases
8%
Minor Salivary Glands
8%
Ebolavirus
8%
Antigens
8%
Thermography
8%
Arthralgia
8%
Raynaud Disease
8%
Autoimmune Hepatitis
8%
Hyperprolactinemia
8%
Randomized Controlled Trials
8%
Interleukin-17
8%
Systems Biology
7%
Experimental Arthritis
7%
Immune Tolerance
7%
Mortality
7%
Papillomavirus Infections
7%
Neural Conduction
7%
Thyroid Gland
7%
Patient Reported Outcome Measures
7%
Precision Medicine
7%
Genetic Background
7%
Allergy and Immunology
7%
Rheumatoid Factor
7%
Lymphocyte Activation
7%
Fibrosis
6%
HLA Antigens
6%
Anti-Idiotypic Antibodies
6%
Prolactin
6%
IC 87114
6%
B-Lymphocytes
6%
Proteins
6%
Focus Groups
6%
Central Tolerance
6%
Genetic Predisposition to Disease
6%
Liver Cirrhosis
6%
Inbred NOD Mouse
6%
Incidence
5%
Inflammation
5%
Catalytic Domain
5%
Phospholipids
5%
Regulatory T-Lymphocytes
5%
Blood Vessels
5%
Medicine
5%
Interleukin-6
5%
Antinuclear Antibodies
5%
HIV-1
5%
Epidemics
5%
Peripheral Tolerance
5%
Odds Ratio
5%
HIV
5%
Confidence Intervals
5%